ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,214.08
0.51%
US Tech 100
17,658.00
0.32%
다우존스 지수
39,387.76
0.85%
Bitcoin
62,888.01
-0.25%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Altimmune Inc (ALT)

  7. Altimmune Inc (ALT) 뉴스

ALT

Altimmune (ALT)

Altimmune Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ALT
일자시간출처헤드라인심볼기업
2024/05/1006:51PR Newswire (US)INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Altimmune Inc. to Contact Law FirmNASDAQ:ALTAltimmune Inc
2024/05/1005:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALTAltimmune Inc
2024/05/0920:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALTAltimmune Inc
2024/05/0920:00GlobeNewswire Inc.Altimmune Announces First Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ALTAltimmune Inc
2024/05/0720:30GlobeNewswire Inc.Altimmune to Participate at Two Upcoming Investor ConferencesNASDAQ:ALTAltimmune Inc
2024/05/0220:30GlobeNewswire Inc.Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024NASDAQ:ALTAltimmune Inc
2024/05/0120:30GlobeNewswire Inc.Altimmune to Participate at Two Upcoming ConferencesNASDAQ:ALTAltimmune Inc
2024/04/2606:24GlobeNewswire Inc.Altimmune Statement on the Passing of Dr. Stephen HarrisonNASDAQ:ALTAltimmune Inc
2024/03/2720:00GlobeNewswire Inc.Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ALTAltimmune Inc
2024/03/2719:57IH Market NewsU.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early TradingNASDAQ:ALTAltimmune Inc
2024/03/2020:30GlobeNewswire Inc.Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024NASDAQ:ALTAltimmune Inc
2024/02/1502:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALTAltimmune Inc
2024/02/1420:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALTAltimmune Inc
2024/02/0608:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/02/0608:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/02/0608:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/02/0208:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/02/0208:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/02/0208:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/02/0208:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/02/0208:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/3008:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/3008:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/3008:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/3008:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/3008:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/2701:49Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALTAltimmune Inc
2024/01/0508:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/0308:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALTAltimmune Inc
2024/01/0221:30GlobeNewswire Inc.Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024NASDAQ:ALTAltimmune Inc
 검색 관련기사 보기:NASDAQ:ALT

최근 히스토리

FX
USDEUR
US Dollar vs Euro
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
FX
USDJPY
US Dollar vs Yen
NYSE
MCD
McDonalds
NYSE
MRK
Merck
CCOM
SILVER
SILVER
NYSE
AXP
American Express
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
COIN
BTCUSD
Bitcoin
AMEX
XLE
Energy Select Sector SPDR
NYSE
NKE
Nike
AMEX
XLF
Financial Select Sector
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유